Hepatitis C - Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ...

Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ...
MSN Money - Feb 23, 2006... is being evaluated alone and in combinations with drugs which comprise the current standard of care for the treatment of chronic Hepatitis C infection in ...

News For Your Web Site
dBusinessNews Portland (press release), OR - Mar 8, 2006... infections.". AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the United States. ...

Coley Pharmaceutical Group Initiates Phase II Clinical Study of ...
PR Newswire (press release), NY - Feb 23, 2006... announced the initiation of a randomized Phase II clinical study of Actilon(TM) (CPG 10101) for the treatment of patients with chronic Hepatitis C infection. ...

Human Genome Sciences: challenging the pegylated interferons
Pharmaceutical Business Review - 2 hours ago... Chronic hepatitis C (CHC) is currently managed through combination therapy consisting of pegylated interferon (pegIFN) and ribavirin (RBV), marketed by Roche ...

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety ...
Medical News Today (press release), UK - Feb 22, 2006... planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin(TM) Anti-Viral in the treatment of chronic hepatitis C virus infection ...

MIGENIX Third Quarter Fiscal 2006 Financial Results Conference ...
Canada NewsWire (press release), Canada - Mar 2, 2006... The Company's clinical programs include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter-related ...